RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Cushing's Syndrome: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
68Ga-Pentixafor PET/MRI for identifying corticotroph adenomas in Cushing disease: a pilot study
Rodrigo Fano et al., Pituitary (16 October 2026)
https://doi.org/10.1007/s11102-026-01770-x
- 2.
Peripheral leukocyte profiles in different clinical forms of hypercortisolism and nonfunctioning adrenal tumors: a retrospective cross-sectional study
Şebnem Burhan et al., BMC Endocrine Disorders (16 October 2026)
https://doi.org/10.1186/s12902-026-02668-2
- 3.
Anesthesia Management Supratentory Tumors, Cushing Syndrome or Not?
, International Journal of Drug Delivery Technology (16 October 2026)
https://doi.org/10.25258/ijddt.16.70s.170
- 4.
Glucagon-like peptide-1 receptor agonist exposure and malignancy risk in patients with endogenous Cushing's syndrome.
Dotan Idit et al., The Journal of clinical endocrinology and metabolism (16 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42233686/
- 5.
Impact of cortisol circadian rhythm on psychological well-being in treated Cushing syndrome: a cross-sectional study.
Theodorou Angeliki et al., The Journal of clinical endocrinology and metabolism (16 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42290613/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Cushing's Syndrome
Cushing's Syndrome is a complex hormonal condition caused by prolonged exposure to high levels of cortisol, most commonly from a pituitary or adrenal tumour, or from long-term glucocorticoid medication. It is associated with central obesity, fragile skin, and serious metabolic complications. Diagnosis is notoriously difficult due to the wide variety of symptoms.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Cushing's Syndrome?
Cushing's Syndrome is a complex hormonal condition caused by prolonged exposure to high levels of cortisol, most commonly from a pituitary or adrenal tumour, or from long-term glucocorticoid medication. It is associated with central obesity, fragile skin, and serious metabolic complications. Diagnosis is notoriously difficult due to the wide variety of symptoms.
How many clinical trials are available for Cushing's Syndrome?
RareWays currently indexes 78 clinical trials for Cushing's Syndrome, of which 11 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Cushing's Syndrome come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Cushing's Syndrome.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.